Shareholders Approve Highly Dilutive Convertible Note & Warrant Authorizations

summarizeSummary

Evaxion A/S shareholders approved new authorizations for convertible loan notes and an increase in warrant authorizations, representing a significant potential for future share dilution.

check_boxKey Events · Financing and Capital Events · EVAX

• Authorization for Convertible Loan Notes

  Shareholders authorized the board to obtain loans against convertible loan notes for up to DKK 73,500,000 nominal value. If fully converted, this could result in the issuance of 294,000,000 new shares, representing a potential dilution of approximately 70.50% of the current outstanding shares. The conversion price will be determined at market price (within +/-10% of the listed price).

• Increased Warrant Authorization

  The existing authorization to issue warrants to employees and management was increased from DKK 6,857,257 to DKK 11,900,000 nominal value. This new authorization allows for the potential issuance of up to 47,600,000 shares, which would result in a potential dilution of approximately 11.41% of the current outstanding shares. The exercise price for these warrants will be at market price.

• New Board Member Elected

  Jens Bitsch-Nørhave was elected as a new member of the board of directors.

auto_awesomeAnalysis · EVAX · Life Sciences

Evaxion A/S shareholders approved significant increases in the company's ability to issue new shares through convertible loan notes and warrants. The authorization for convertible loan notes could lead to a potential dilution of approximately 70.50% of current outstanding shares, while the increased warrant authorization could result in an additional 11.41% dilution. These authorizations provide the company with mechanisms for future capital raises and employee incentives but signal a substantial potential for dilution for existing shareholders. The approval of a new board member is a routine governance update.